BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 5302873)

  • 1. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 3. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
    Deberdt R
    Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating severe maladjustment with pipamperone (Dipiperon).
    Noordhuizen GJ
    Acta Psychiatr Belg; 1977; 77(6):754-60. PubMed ID: 610354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sedalium in psychiatry within its tranquilizing and neuroleptic boundaries].
    Volmat R; Beaudouin JL; Allers G; Vittouris N; Dufay F; Bizouard P
    Encephale; 1972; 61(2):163-82. PubMed ID: 4634905
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of the butyrophenones. Floropipamide (Dipiperon), methylperon (Buronil), trifluperidol (Psicoperidol)].
    Kristjansen P
    Nord Psykiatr Tidsskr; 1968; 22(3):235-48. PubMed ID: 5711258
    [No Abstract]   [Full Text] [Related]  

  • 7. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
    Van Renynghe de Voxvrie G; De Bie M
    Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone].
    Fouks ; Mathis ; Gilbert ; Ferragu ; Houssait ; Lerno
    Ann Med Psychol (Paris); 1966 Dec; 124(5):677-81. PubMed ID: 5973302
    [No Abstract]   [Full Text] [Related]  

  • 9. [AHR-2277: a new major neuroleptic with minimal neurological side-effects].
    Denber HC
    Ann Med Psychol (Paris); 1973 Jan; 1(1):131-8. PubMed ID: 4723202
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary observations on the clinical use in psychiatry of a recent derivative of butyrophenone (Luvatrene)].
    Gori EC; Bonasegla F
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1304-14. PubMed ID: 5997230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Character disorders and their treatment by pipamperone].
    Fouks ; PĂ©rivier ; Houssalt ; Gilbert ; Ferragu
    Ann Med Psychol (Paris); 1968 Feb; 1(2):255-8. PubMed ID: 5651948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
    Haugen T
    Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
    [No Abstract]   [Full Text] [Related]  

  • 13. [Note on the use of dihydrogenated derivatives of ergotoxin (Hydergine) and their association with psychopharmacology in the treatment of aged neuropsychiatric patients].
    Bertolotti P; Spaggiari G
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1243-58. PubMed ID: 4968439
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of trifluperidol therapy.
    Szobor A
    Ther Hung; 1969; 17(3):109-14. PubMed ID: 5356925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of a new psychopharmacological agent: piperonyl].
    Gazzaniga GC; Terzi GF
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Aug; 95(4):799-807. PubMed ID: 5114798
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with a new butyrophenone derivative (Buronil).
    Vangtorp A; Simmelsgaard H; Mellegaard M
    Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877
    [No Abstract]   [Full Text] [Related]  

  • 17. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial with R-3345].
    Bastos O; Carvalho RG
    J Bras Psiquiatr; 1970; 19(3):251-6. PubMed ID: 4949175
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic experiences with oxazepam--a derivative of the benzodiazepine series--in child and adolescent psychiatry].
    Nievoll A
    Wien Klin Wochenschr; 1971 Apr; 83(14):251-4. PubMed ID: 5559790
    [No Abstract]   [Full Text] [Related]  

  • 20. factors influencing response to major tranquilizer medications.
    Kimbell I; Overall JE; Faibish GM; Pokorny AD
    Dis Nerv Syst; 1972 Apr; 33(4):223-30. PubMed ID: 5029910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.